Clopidogrel vs DAPT in Acute Coronary Syndromes and High Ischemic/Bleeding Risk
This randomized clinical trial evaluates clopidogrel monotherapy vs dual antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary interventions who are at high bleeding and ischemic risk.